FDA Inspection
Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals, Inc. – FDA Inspection, Jun 22, 2023
Record Details
This FDA Inspection record concerns Catalyst Pharmaceuticals, Inc., with an inspection on June 22, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a58f72cb-a4f4-400c-bf93-f1345e630363
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1209618
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Catalyst Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Catalyst Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.